D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.93% |
| 2 | Consumer Discretionary | 10.48% |
| 3 | Healthcare | 8.56% |
| 4 | Communication Services | 8.41% |
| 5 | Financials | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
908 Devices
MASS
$288M
| $581K | ﹤0.01% |
+11,971
| New | +$684K |
|
3302
XPeng
XPEV
$12.1B
| $581K | ﹤0.01% |
15,913
-2,660,421
| -99% | -$111M |
|
3303
CorVel
CRVL
$3.09B
| $578K | ﹤0.01% |
16,920
-3,327
| -16% | -$116K |
|
3304
First Internet Bancorp
INBK
$233M
| $578K | ﹤0.01% |
16,420
+1,262
| +8% | +$42.2K |
|
3305
CALL
Sprout Social
SPT
$513M
| $578K | ﹤0.01% |
+10,000
| New | +$627K |
|
3306
Orion Group Holdings
ORN
$493M
| $574K | ﹤0.01% |
94,607
-104,233
| -52% | -$600K |
|
3307
Saratoga Investment
SAR
$316M
| $573K | ﹤0.01% |
22,638
-21,925
| -49% | -$508K |
|
3308
Luxfer Holdings
LXFR
$461M
| $572K | ﹤0.01% |
26,861
-3,534
| -12% | -$66.5K |
|
|
ASRT
3309
DELISTED
Assertio
ASRT
| $571K | ﹤0.01% |
13,955
-24,735
| -64% | -$1.23M |
|
3310
Fulgent Genetics
FLGT
$554M
| $571K | ﹤0.01% |
+5,905
| New | +$610K |
|
|
FLXN
3311
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $570K | ﹤0.01% |
63,641
-14,773
| -19% | -$169K |
|
3312
Kymera Therapeutics
KYMR
$9.11B
| $569K | ﹤0.01% |
14,645
-16,947
| -54% | -$1.02M |
|
3313
CALL
Lakeland Industries
LAKE
$107M
| $568K | ﹤0.01% |
+20,400
| New | +$634K |
|
3314
Unitil
UTL
$1B
| $564K | ﹤0.01% |
+12,334
| New | +$539K |
|
|
PMT
3315
PennyMac Mortgage Investment
PMT
$841M
| $561K | ﹤0.01% |
28,652
-1,447,169
| -98% | -$26.8M |
|
|
PACW
3316
CALL
DELISTED
PacWest Bancorp
PACW
| $561K | ﹤0.01% |
+14,700
| New | +$516K |
|
|
DSAC
3317
DELISTED
Duddell Street Acquisition Corp. Class A Ordinary Shares
DSAC
| $561K | ﹤0.01% |
+57,392
| New | +$585K |
|
|
ARNA
3318
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $561K | ﹤0.01% |
+8,091
| New | +$623K |
|
3319
BlackRock Corporate High Yield Fund
HYT
$1.36B
| $558K | ﹤0.01% |
47,500
| – | – |
|
|
NESR
3320
National Energy Services Reunited Corp
NESR
$2.68B
| $556K | ﹤0.01% |
+44,937
| New | +$528K |
|
|
OCA
3321
DELISTED
Omnichannel Acquisition Corp.
OCA
| $556K | ﹤0.01% |
+57,012
| New | +$577K |
|
3322
Trex
TREX
$4.53B
| $553K | ﹤0.01% |
6,040
+3,163
| +110% | +$297K |
|
|
AAT
3323
American Assets Trust
AAT
$1.5B
| $552K | ﹤0.01% |
17,001
-140,146
| -89% | -$4.33M |
|
3324
ScottsMiracle-Gro
SMG
$4.04B
| $552K | ﹤0.01% |
+2,252
| New | +$510K |
|
3325
CALL
3D Systems Corp
DDD
$428M
| $549K | ﹤0.01% |
+20,000
| New | +$661K |
|
Similar funds
D.E. Shaw & Co's Q1 2021 Portfolio in Review
As of Q1 2021, D.E. Shaw & Co held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
D.E. Shaw & Co withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Baidu worth $627M.
- D.E. Shaw & Co's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- D.E. Shaw & Co added most to Tesla in Q1 2021, an estimated $862M increase.
- D.E. Shaw & Co's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- D.E. Shaw & Co fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- D.E. Shaw & Co's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- D.E. Shaw & Co opened 825 new positions and closed 730 in Q1 2021.
- D.E. Shaw & Co's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.